BackAdial Pharmaceuticals- Warrants (31/07/2023) Overview
Adial Pharmaceuticals Inc - Warrants (31/07/2023)

Adial Pharmaceuticals- Warrants (31/07/2023) P/E Ratio

Adial Pharmaceuticals- Warrants (31/07/2023) (ADILW) has a P/E ratio of -0.38, below the Healthcare sector average of 26.85.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

-0.38

P/E Ratio

-0.38

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Adial Pharmaceuticals- Warrants (31/07/2023) (ADILW) FAQ

As of the most recent data, ADILW shows a P/E ratio of -0.38. That is below the Healthcare sector average of 26.85. Scroll down for historical charts and peer comparison views.

The Healthcare sector average P/E ratio is about 26.85. Adial Pharmaceuticals- Warrants (31/07/2023) is at -0.38, which is lower that average. That is roughly 101.4% below the sector mean. Use the comparison chart on this page to see how ADILW stacks up against individual peers as well.

Investors watch ADILW's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Adial Pharmaceuticals- Warrants (31/07/2023)'s latest reading is -0.38. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Adial Pharmaceuticals- Warrants (31/07/2023)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -0.38) with ownership activity and broader fundamentals.

The Healthcare average P/E ratio is about 26.85, while ADILW is at -0.38. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.